Welcome to our dedicated page for Credit Accep Mich SEC filings (Ticker: CACC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Struggling to untangle Credit Acceptance’s layered credit-loss tables or securitization waterfalls? Credit Acceptance Corp. (CACC) filings often exceed 250 pages, mixing sub-prime loan metrics with complex residual revenue accounting—data critical for assessing portfolio health yet time-consuming to digest.
Stock Titan solves that problem. Our AI delivers plain-English, point-by-point breakdowns for every filing type—from the Credit Acceptance annual report 10-K simplified to each Credit Acceptance quarterly earnings report 10-Q filing. Need to track sudden events? Receive instant alerts the moment a Credit Acceptance 8-K material events explained disclosure hits EDGAR. Curious about executive behavior? Monitor Credit Acceptance insider trading Form 4 transactions and get Credit Acceptance Form 4 insider transactions real-time summaries that highlight buying or selling before headline news.
Here’s what you can uncover fast:
- Dealer payout structures and credit-loss assumptions hidden deep in the 10-K
- Quarter-over-quarter loan performance trends with AI-generated charts
- Credit Acceptance proxy statement executive compensation details mapped against ROE targets
- Credit Acceptance earnings report filing analysis capturing net charge-off shifts in seconds
Whether you’re a portfolio manager understanding Credit Acceptance SEC documents with AI or a credit analyst comparing insider sentiment via Credit Acceptance executive stock transactions Form 4, Stock Titan delivers comprehensive coverage and real-time context so you can act decisively.
Credit Acceptance Corp. (NASDAQ: CACC) has filed an 8-K announcing execution of the Fourteenth Amendment to its $― revolving secured line of credit with Comerica Bank and a syndicate of lenders. The sole material change is an extension of the revolving period by 12 months—from 22 Jun 2027 to 22 Jun 2028. All other economic covenants, collateral requirements and pricing terms remain unchanged. As of the amendment date (24 Jun 2025), the Company had no outstanding borrowings under the facility, leaving the entire committed capacity available as contingent liquidity. The amendment appears to be routine and does not create additional debt; rather, it preserves an existing liquidity back-stop for a longer horizon. A related press release (Ex. 99.1) and the amended agreement (Ex. 4.155) were filed concurrently.
The filing does not disclose the credit line’s current size, pricing grid, or covenant thresholds, and it contains no earnings guidance, financial results, or changes in strategy. Therefore, the immediate market impact is expected to be modest, though the extension modestly strengthens the Company’s liquidity profile and financial flexibility.
Credit Acceptance Corp (CACC) Chief Marketing and Product Officer Andrew K. Rostami reported insider trading activity on June 20, 2025. The executive sold 375 shares at $505.29 per share, resulting in a transaction value of approximately $189,484.
Following the transaction, Rostami holds 25,478.5 shares, including 23,572 unvested restricted stock units granted under the Company's Incentive Compensation Plan. Additionally, the executive maintains 16,000 stock options with an exercise price of $585.93, which vest in four equal annual installments starting April 18, 2023 and expire on April 18, 2028.
This Form 4 filing indicates a relatively small disposition of shares by a senior executive while maintaining a substantial equity position in the company through direct ownership, RSUs, and options, suggesting continued alignment with shareholder interests.
Credit Acceptance Corp (NASDAQ: CACC) has filed a Form 144 notice for a proposed sale of securities by an insider. The filing details plans to sell 375 shares of common stock with an aggregate market value of $189,483.75, representing a small portion of the total 11,603,475 shares outstanding.
The shares to be sold were acquired through two restricted stock vesting events:
- 90 shares vested on October 31, 2023
- 285 shares vested on April 18, 2024
The planned sale is scheduled for June 20, 2025 through Fidelity Brokerage Services. The securities were originally acquired as compensation through restricted stock vesting. The filing indicates no other sales by the insider in the past 3 months, suggesting this is an isolated transaction rather than part of a larger selling pattern.